Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - betaxolol hcl eqv betaxolol - solution - 0.25% w/v - betaxolol hcl eqv betaxolol 0.25% w/v

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - betaxolol hcl 0.56% w/v eqv betaxolol - solution - 5.6 mg/ml - betaxolol hcl 0.56% w/v eqv betaxolol 0.5% w/v

Singapore - English - HSA (Health Sciences Authority)

santen pharmaceutical asia pte. ltd. - timolol maleate 6.83 mg eqv timolol - solution - 0.50% - timolol maleate 6.83 mg eqv timolol 5.00 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 10 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 2 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.

Australia - English - Department of Health (Therapeutic Goods Administration)

australasian medical & scientific ltd - sodium tetradecyl sulfate, quantity: 30 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; water for injections; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; sodium hydroxide - indications as at 09 june 2005 : the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give rise to adverse reactions.

Singapore - English - HSA (Health Sciences Authority)

santen pharmaceutical asia pte. ltd. - timolol maleate eqv timolol - solution - timolol maleate eqv timolol 5 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

eight brook pty ltd - zinc oxide, quantity: 215 mg/g - cream - excipient ingredients: purified water; alkyl (c12-15) benzoate; isostearic acid; polyhydroxystearic acid; iron oxide yellow; triethoxycaprylylsilane; diazolidinyl urea; mica; iron oxide red; citric acid; glycerol; terminalia ferdinandiana; glyceryl polymethacrylate; propylene glycol; palmitoyl oligopeptide; titanium dioxide; phenoxyethanol; xanthan gum; disodium edetate; dl-alpha-tocopheryl acetate; cyclomethicone; peg-20 methyl glucose sesquistearate; methyl glucose sesquistearate; isostearyl neopentanoate; cetostearyl alcohol; cetearyl glucoside; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

eight brook pty ltd - zinc oxide, quantity: 215 mg/g - cream - excipient ingredients: purified water; alkyl (c12-15) benzoate; isostearic acid; polyhydroxystearic acid; triethoxycaprylylsilane; diazolidinyl urea; phenoxyethanol; citric acid; glycerol; terminalia ferdinandiana; glyceryl polymethacrylate; propylene glycol; palmitoyl oligopeptide; xanthan gum; disodium edetate; dl-alpha-tocopheryl acetate; cyclomethicone; peg-20 methyl glucose sesquistearate; methyl glucose sesquistearate; isostearyl neopentanoate; cetostearyl alcohol; cetearyl glucoside; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 30 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - zinc oxide, quantity: 216 mg/g - stick - excipient ingredients: octyldodecyl neopentanoate; alkyl (c12-15) benzoate; polyethylene; colloidal anhydrous silica; synthetic wax; neopentyl glycol dioctanoate; ceresin; isopropyl myristate; adipic acid/diethylene glycol/glycerin crosspolymer; triethoxycaprylylsilane; neopentyl glycol diisostearate; caprylyl glycol; dl-alpha-tocopheryl acetate - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)